30 Maine facilities supplied by suspended Mass. pharmacy
Federal inspectors report that 30 Maine health organizations received products from a Massachusetts pharmacy linked to an outbreak of fungal meningitis that has killed 23 people.
Clarification: No Maine facilities reported receiving the injectable steroids connected directly to the outbreak, but did use the same pharmaceutical company — the New England Compounding Center — as a supplier.
The Bangor Daily News reported that a list released earlier this week contained only 14 health organizations in Maine. That list was revised by the U.S. Food and Drug Administration and now includes 30 Maine facilities.
The paper reported that the state is now monitoring 74 Maine residents who received treatment in New Hampshire with the steroid injections that are linked to the New England Compounding Center, based in Framingham, Mass.
Meningitis is a potentially deadly inflammation of the lining around the brain and spinal cord. Fungal meningitis is a rare form of the condition that usually results from fungus spreading through blood to the spinal cord and it is not contagious.
About 97% of the affected patients have been contacted by health officials, the BDN reported.
The pharmacy has stopped production and all of its products have been recalled as federal investigators suspect up to 14,000 patients may have received the potentially infectious steroid.
DOWNLOAD PDFs
List of Maine health care organizations supplied by the New England Compounding Center
Most Recent
Most Recent
Comments